JUBILANT PHARMOVA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 735.2 INR | +1.30% |
|
+0.20% | +34.72% |
| 06-25 | Jubilant Pharmova Arm Completes Prepayment of $75 Million Term Loan | MT |
| 06-18 | Jubilant Pharmova Gets 15 Observations from US FDA for Unit's Manufacturing Facility in Canada; Shares Dip 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Companyâs segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services, and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.
Sector
Pharmaceuticals
Calendar
2024-07-17
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +34.72% | 1.38B | |
| +54.91% | 815B | |
| +44.25% | 654B | |
| -6.15% | 354B | |
| +21.37% | 337B | |
| +11.05% | 302B | |
| +18.45% | 247B | |
| +2.09% | 229B | |
| +13.03% | 219B | |
| +8.85% | 171B |
- Stock Market
- Equities
- JUBLPHARMA Stock
- News Jubilant Pharmova Limited
- Jubilant Pharmova Gets Three US FDA Observations for Unit's Facility in Washington; Shares Drop 3%
